Lifevantage Corp SEC filings LFVN
Lifevantage Corp has 1,001 filings in SEC EDGAR's recent list, going back to Oct 28, 2009. Its latest annual report, Form ARS, was filed on Sep 18, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 6, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 3, 2026 | — |
| S-3 | Shelf registration | Mar 10, 2026 | — |
| S-8 | Employee stock plan registration | Nov 14, 2025 | — |
| S-8 | Employee stock plan registration | Nov 21, 2024 | — |
| S-8 | Employee stock plan registration | Aug 28, 2024 | — |
| S-3 | Shelf registration | Mar 31, 2023 | — |
| S-8 | Employee stock plan registration | Jan 11, 2021 | — |
| S-3 | Shelf registration | Mar 24, 2020 | — |
| S-8 | Employee stock plan registration | Nov 30, 2018 | — |
| S-8 | Employee stock plan registration | Mar 27, 2017 | — |
| S-8 | Employee stock plan registration | Nov 19, 2014 | — |
| S-8 | Employee stock plan registration | Aug 21, 2012 | — |
| S-8 | Employee stock plan registration | Jun 23, 2011 | — |
Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LFVN (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Lehi, UT
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 849146
- Former names
- LIFELINE THERAPEUTICS, INC. (until Dec 6, 2006); YAAK RIVER RESOURCES INC (until Sep 28, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.